Enorama Pharma AB (ERMA) — Capital Reinvestment Ratio
Enorama Pharma AB (ERMA) has a Capital Reinvestment Ratio of 4.15x as of December 2015, meaning it reinvests 4% of its operating cash flow (Skr480.00K) in capital expenditures (Skr1.99 Million). Check ERMA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Enorama Pharma AB Capital Reinvestment Ratio (2014–2015)
This chart tracks Enorama Pharma AB's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see Enorama Pharma AB cash flow conversion.
Annual Capital Reinvestment Ratio for Enorama Pharma AB (2014–2015)
Year-by-year Capital Reinvestment Ratio for Enorama Pharma AB from 2014 to 2015. See Enorama Pharma AB (ERMA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 4.15x | Skr480.00K | Skr1.99 Million | ▼ -7.8% |
| 2014 | 4.50x | Skr307.00K | Skr1.38 Million | — |